Technical Analysis for MREO - Mereo BioPharma Group plc

Grade Last Price % Change Price Change
D 4.28 1.66% 0.07
MREO closed up 1.66 percent on Friday, November 1, 2024, on 67 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat

Date Alert Name Type % Chg
Inside Day Range Contraction 1.66%
BB Squeeze Ended Range Expansion 1.66%
Bollinger Band Squeeze Range Contraction 0.71%
Outside Day Range Expansion 0.71%
MACD Bearish Centerline Cross Bearish 1.66%
Bollinger Band Squeeze Range Contraction 1.66%
NR7 Range Contraction 1.66%
Bollinger Band Squeeze Range Contraction 1.90%
BB Squeeze Started Range Contraction 1.90%
50 DMA Resistance Bearish 0.47%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 18 hours ago
60 Minute Opening Range Breakdown about 20 hours ago
Rose Above Previous Day's High about 22 hours ago
10 DMA Resistance about 22 hours ago
Up 2% about 22 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Mereo is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare diseases. Mereo's strategy is to selectively acquire product candidates that have substantial preclinical, clinical and manufacturing data packages. Mereo's four product candidates have previously generated positive clinical data for Mereo's target indications or in related indications. Mereo has commenced randomized Phase 2 clinical trials for all four of the product candidates. In connection with the merger with OncoMed, Mereo added two candidates to its pipeline, Navicixizumab and Etigilimab.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Drug Discovery Rare Diseases Clinical Research Clinical Trial Compugen

Is MREO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.02
52 Week Low 1.86
Average Volume 704,537
200-Day Moving Average 3.73
50-Day Moving Average 4.36
20-Day Moving Average 4.33
10-Day Moving Average 4.29
Average True Range 0.20
RSI (14) 48.72
ADX 14.64
+DI 16.83
-DI 20.32
Chandelier Exit (Long, 3 ATRs) 4.13
Chandelier Exit (Short, 3 ATRs) 4.64
Upper Bollinger Bands 4.63
Lower Bollinger Band 4.03
Percent B (%b) 0.42
BandWidth 13.96
MACD Line -0.01
MACD Signal Line 0.01
MACD Histogram -0.0214
Fundamentals Value
Market Cap 600.24 Million
Num Shares 140 Million
EPS -0.32
Price-to-Earnings (P/E) Ratio -13.38
Price-to-Sales 79.09
Price-to-Book 7.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.46
Resistance 3 (R3) 4.45 4.39 4.43
Resistance 2 (R2) 4.39 4.34 4.39 4.42
Resistance 1 (R1) 4.33 4.31 4.36 4.34 4.41
Pivot Point 4.27 4.27 4.28 4.27 4.27
Support 1 (S1) 4.21 4.22 4.24 4.22 4.15
Support 2 (S2) 4.15 4.19 4.15 4.14
Support 3 (S3) 4.09 4.15 4.13
Support 4 (S4) 4.10